APA

Pönisch W., Heyn S., Beck J., Wagner I., Mohren M., Hoffmann F. A., Lange T., Schmalfeld M., Zehrfeld T., Schwarzer A., Winkelmann C., Edelmann T., Röhrborn R., Hebenstreit K., Al-Ali H. K., Jäkel N. & Niederwieser D. (20140204). Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077. : British journal of haematology.

Chicago

Pönisch Wolfram, Heyn Simone, Beck Juliane, Wagner Ina, Mohren Martin, Hoffmann Franz A, Lange Thoralf, Schmalfeld Marion, Zehrfeld Thomas, Schwarzer Andreas, Winkelmann Cornelia, Edelmann Thomas, Röhrborn Ramona, Hebenstreit Karin, Al-Ali Haifa K, Jäkel Nadja and Niederwieser Dietger. 20140204. Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077. : British journal of haematology.

Harvard

Pönisch W., Heyn S., Beck J., Wagner I., Mohren M., Hoffmann F. A., Lange T., Schmalfeld M., Zehrfeld T., Schwarzer A., Winkelmann C., Edelmann T., Röhrborn R., Hebenstreit K., Al-Ali H. K., Jäkel N. and Niederwieser D. (20140204). Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077. : British journal of haematology.

MLA

Pönisch Wolfram, Heyn Simone, Beck Juliane, Wagner Ina, Mohren Martin, Hoffmann Franz A, Lange Thoralf, Schmalfeld Marion, Zehrfeld Thomas, Schwarzer Andreas, Winkelmann Cornelia, Edelmann Thomas, Röhrborn Ramona, Hebenstreit Karin, Al-Ali Haifa K, Jäkel Nadja and Niederwieser Dietger. Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077. : British journal of haematology. 20140204.